Front > Healthcare, biotech

Healthcare, biotech

drugs, medicine  picture: thinkstock Gastro-intestinal drug co RDD Pharma raises $9.5m

The Israeli company will use the new funding to advance programs in anal fissure, fecal incontinence, radiation colitis/proctitis and pruritus ani.

drug development Entera Bio files for $50m Nasdaq IPO

Phase II/III trials for the Israeli company's hypoparathyroidism treatment are due to begin in the first quarter of 2018.

Twitter Facebook Linkedin RSS Newsletters גלובס MAD Conference 2017